Cargando…

Yao Syndrome: A Potential Role and Association of Vasoactive Intestinal Peptide with NOD2

Nucleotide-binding oligomerization domain containing protein 2 (NOD2) is a cytosolic receptor. Both NOD2 and vasoactive intestinal peptide (VIP) are critical in regulation of immune and inflammatory response. Yao syndrome (YAOS, OMIM 617321) is an autoinflammatory disease associated with specified N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navetta-Modrov, Brianne, Ghebrehiwet, Berhane, Yao, Qingping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524777/ https://www.ncbi.nlm.nih.gov/pubmed/36467900 http://dx.doi.org/10.2478/rir-2021-0005

Ejemplares similares

Macroglobulinemia and Autoinflammatory Disease
por: Navetta-Modrov, Brianne, et al.
Publicado: (2021)

Implications of combined NOD2 and other gene mutations in autoinflammatory diseases
por: Nomani, Hafsa, et al.
Publicado: (2023)

NOD2 Versus MEFV: Differential Diagnosis of Yao Syndrome and Familial Mediterranean Fever
por: Yao, Qingping, et al.
Publicado: (2021)

The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness
por: Kuperberg, Stephen J., et al.
Publicado: (2021)

NOT THE VACCINE, BUT ANAPHYLAXIS TO THE COVID-19 VIRUS ITSELF
por: PAROYA, AZZAM, et al.
Publicado: (2022)

Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab
por: Rabascall, Carlos X, et al.
Publicado: (2021)

Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016)

Inpatient Rheumatology Consultation Prompted by Positive Autoantibodies in Patients Receiving Intravenous Immunoglobulin Therapy: A Case Series and Literature Review
por: Fnu, Zarlasht, et al.
Publicado: (2023)

Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
por: Hermel, Melody, et al.
Publicado: (2021)

Treatment of refractory Yao syndrome with canakinumab
por: Brailsford, Caroline J., et al.
Publicado: (2022)

Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor
por: Belei, Oana, et al.
Publicado: (2023)

Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)

Vasoactive Intestinal Peptide-Secreting Pheochromocytoma: A Case Report and Review of Literature
por: Yee, Shelby K., et al.
Publicado: (2022)

Yao syndrome: Cyclical folliculitis, fevers, and abdominal pain
por: Esse, Ilhan, et al.
Publicado: (2023)

Role of Vasoactive Intestinal Peptide in Promoting the Pathogenesis of Eosinophilic Esophagitis (EoE)
por: Verma, Alok K., et al.
Publicado: (2017)

Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
por: Chaudhury, Dipesh, et al.
Publicado: (2008)

Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
Publicado: (1987)

Vasoactive intestinal peptide axis is dysfunctional in patients with Graves’ disease
por: Carrión, M., et al.
Publicado: (2020)

The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021)

Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome
por: Goff, Kevin M, et al.
Publicado: (2019)

Role of tear vasoactive intestinal peptide on dry eyes after laser keratorefractive surgery
por: Kang, Yang, et al.
Publicado: (2023)

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes
por: Hou, Xintong, et al.
Publicado: (2022)

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility
por: Nassif, A., et al.
Publicado: (1995)

Vasoactive Intestinal Peptide and Its Receptors in Human Ovarian Cortical Follicles
por: Gabbay-Benziv, Rinat, et al.
Publicado: (2012)

Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
por: Li, Bo, et al.
Publicado: (2019)

Vasoactive intestinal peptide regulates ileal goblet cell production in mice
por: Schwerdtfeger, Luke A., et al.
Publicado: (2020)

Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
por: Ataallah, Basma, et al.
Publicado: (2020)

Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension
por: Isaka, Mitsuhiro, et al.
Publicado: (2021)

Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid
por: Privalov, Evgeny, et al.
Publicado: (2023)

Pancreatic Vasoactive Intestinal Peptide-Producing Tumor as a Rare Cause of Acute Diarrhea and Severe Hypokalemia
por: Giampatzis, Vasilios, et al.
Publicado: (2023)

Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity
por: Seoane, Iria V., et al.
Publicado: (2015)

Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis
por: Eger, Michal, et al.
Publicado: (2021)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a review
por: Wu, Dongmei, et al.
Publicado: (2011)

Serum Levels of Vasoactive Intestinal Peptide as a Prognostic Marker in Early Arthritis
por: Martínez, Carmen, et al.
Publicado: (2014)

Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception
por: Zhu, Zhen-chuang, et al.
Publicado: (2019)

Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system
por: Iwasaki, Mari, et al.
Publicado: (2019)

Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report
por: Thivacaren, Sritharan, et al.
Publicado: (2022)

Vasoactive intestinal peptide–VIPR2 signaling regulates tumor cell migration
por: Asano, Satoshi, et al.
Publicado: (2022)

Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge
por: Lopes, Sara, et al.
Publicado: (2022)

Vasoactive Peptides: Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets
por: Khodabakhsh, Pariya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nfest0gobo0bs7av8fb90hc0md